Francesca Orlandi

Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.

J. Liao, Polly D. Gregor, Jedd D. Wolchok et al. · PubMed · 2006 · 133 citations

Medicine, Immunology, Oncology +17

⁶⁸Ga/¹⁷⁷Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology

Simone U. Dalm, Ingrid L. Bakker, Erik de Blois et al. · Journal of Nuclear Medicine · 2016 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.

Jianda Yuan, Geoffrey Y. Ku, Humilidad F. Gallardo et al. · PubMed · 2009 · 80 citations · Full text

Medicine, Immunology, Oncology +17

MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of ⁶⁸Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients

Leonhard Gruber, Luis David Jiménez‐Franco, Clemens Decristoforo et al. · Journal of Nuclear Medicine · 2020 · 60 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika et al. · Molecules · 2017 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16